Literature DB >> 22098284

Radiotherapy-induced nausea and vomiting.

Kristopher Dennis1, Ernesto Maranzano, Carlo De Angelis, Lori Holden, Shun Wong, Edward Chow.   

Abstract

Radiotherapy-induced nausea and vomiting (RINV) are common and troublesome symptoms experienced by patients undergoing radiotherapy. Although quality of life and symptom control now figure prominently in evaluations of cancer therapies, progress in RINV research and clinical prevention has been slow. This article summarizes the major guidelines for the prevention of RINV; their structure, recommendations, evidence base and notable issues. It also examines the current challenges and controversies related to RINV clinical management and research, and provides possible solutions for them that could ultimately lead to better patient care.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22098284     DOI： 10.1586/erp.11.77

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN： 1473-7167            Impact factor:   2.217


  10 in total

1.  Phase II study to evaluate the safety and efficacy of intravenous palonosetron (PAL) in primary malignant glioma (MG) patients receiving standard radiotherapy (RT) and concomitant temozolomide (TMZ).

Authors:  Mary Lou Affronti; Sarah Woodring; Karen Allen; John Kirkpatrick; Katherine B Peters; James E Herndon; Frances McSherry; Patrick N Healy; Annick Desjardins; James J Vredenburgh; Henry S Friedman
Journal:  Support Care Cancer       Date:  2016-06-06       Impact factor: 3.603

2.  International radiation oncology trainee decision making in the management of radiotherapy-induced nausea and vomiting.

Authors:  Kristopher Dennis; Liying Zhang; Stephen Lutz; Yvette van der Linden; Angela van Baardwijk; Tanya Holt; Jean-Leon Lagrange; Palmira Foro-Arnalot; Lea-Choung Wong; Ernesto Maranzano; Kam-Hung Wong; Rico Liu; Vassilios Vassiliou; Benjamin W Corn; Carlo De Angelis; Lori Holden; C Shun Wong; Edward Chow
Journal:  Support Care Cancer       Date:  2013-02-26       Impact factor: 3.603

Review 3.  2016 updated MASCC/ESMO consensus recommendations: prevention of radiotherapy-induced nausea and vomiting.

Authors:  Christina H Ruhlmann; Franziska Jahn; Karin Jordan; Kristopher Dennis; Ernesto Maranzano; Alexander Molassiotis; Fausto Roila; Petra Feyer
Journal:  Support Care Cancer       Date:  2016-09-13       Impact factor: 3.603

4.  Symptom clusters of gastrointestinal cancer patients undergoing radiotherapy using the Functional Living Index-Emesis (FLIE) quality-of-life tool.

Authors:  Michael Poon; Kristopher Dennis; Carlo DeAngelis; Hans Chung; Jordan Stinson; Liying Zhang; Gillian Bedard; Erin Wong; Marko Popovic; Nicholas Lao; Natalie Pulenzas; Shun Wong; Paul Cheon; Edward Chow
Journal:  Support Care Cancer       Date:  2015-01-27       Impact factor: 3.603

Review 5.  A systematic review of methodologies, endpoints, and outcome measures in randomized trials of radiation therapy-induced nausea and vomiting.

Authors:  Kristopher Dennis; Rehana Jamani; Clare McGrath; Leila Makhani; Henry Lam; Patrick Bauer; Carlo De Angelis; Natalie Coburn; C Shun Wong; Edward Chow
Journal:  Support Care Cancer       Date:  2017-03-31       Impact factor: 3.603

6.  A novel prospective descriptive analysis of nausea and vomiting among patients receiving gastrointestinal radiation therapy.

Authors:  Michael Poon; Jonathan Hwang; Kristopher Dennis; Carlo DeAngelis; Liying Zhang; Hans Chung; Jordan Stinson; Shun Wong; Natalie Pulenzas; Edward Chow
Journal:  Support Care Cancer       Date:  2015-09-16       Impact factor: 3.603

7.  Impact of radiation-induced nausea and vomiting on quality of life.

Authors:  Caitlin Yee; Leah Drost; Liying Zhang; Bo Angela Wan; Vithusha Ganesh; May Tsao; Elizabeth Barnes; Mark Pasetka; Carlo DeAngelis; Edward Chow
Journal:  Support Care Cancer       Date:  2018-05-28       Impact factor: 3.603

8.  Ondansetron rapidly dissolving film for the prophylactic treatment of radiation-induced nausea and vomiting-a pilot study.

Authors:  E Wong; N Pulenzas; G Bedard; C DeAngelis; L Zhang; M Tsao; C Danjoux; N Thavarajah; B Lechner; R McDonald; P M Cheon; E Chow
Journal:  Curr Oncol       Date:  2015-06       Impact factor: 3.677

Review 9.  Prophylactic Management of Radiation-Induced Nausea and Vomiting.

Authors:  Petra Feyer; Franziska Jahn; Karin Jordan
Journal:  Biomed Res Int       Date:  2015-09-03       Impact factor: 3.411

10.  A prospective cohort study of patient-reported vomiting, retching, nausea and antiemetic use during neoadjuvant long-course radiation therapy and concurrent 5-fluorouracil-based chemotherapy for rectal adenocarcinoma.

Authors:  Kristopher Dennis; Liang Zeng; Carlo De Angelis; Hans Chung; Natalie Coburn; Edward Chow; C Shun Wong
Journal:  Clin Transl Radiat Oncol       Date:  2018-04-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.